Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Citalopram hydrobromide

Citalopram hydrobromide

pharmaceutical raw materials
Citalopram hydrobromide structure

Citalopram hydrobromide 

structure
  • CAS No:

    59729-32-7

  • Formula:

    C20H21FN2O.BrH

  • Chemical Name:

    Citalopram hydrobromide

  • Synonyms:

    5-Isobenzofurancarbonitrile,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-,hydrobromide (1:1);5-Isobenzofurancarbonitrile,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-,monohydrobromide;Citalopram hydrobromide;Seropram;Cipramil;Celexa;Cipram;Lupram;Apertia;Sepram;Lu 10-171B;Elopram;Prisdal;(±)-Citalopram hydrobromide;Lecital;S-Pram;Pramcit;Cheer;Citopram;[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-isobenzofuran-5-carbonitrile hydrobromide;1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile hydrobromide

  • Categories:

    Active Pharmaceutical Ingredients  >  Nervous System Drugs

Description

Citalopram hydrobromide is an antidepressant drug of the selective serotonin reuptake inhibitor (SSRI) class. It has US FDA approval to treat major depression.


A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.

Citalopram hydrobromide Basic Attributes

405.30400

404.09000

261-890-6

758684

DTXSID40872344

2932999099

Characteristics

36.26000

4.77108

White Crystalline Powder

182-183 °C

182-188ºC

212.8ºC

Sparingly soluble in water and soluble in ethanol.

-20ºC Freezer

Safety Information

III

6.1(b)

UN 3249

3

11-23/24/25-39/23/24/25

7-16-36/37-45

NP6313500

F,T

Stable. Incompatible with strong oxidizing agents.

P210-P260-P280-P301 + P310-P311

H302

|Warning|H302 (96.49%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P273, P301+P312, P330, P391, and P501|Aggregated GHS information provided by 114 companies from 14 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)|Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Serotonin Uptake Inhibitors.)

Celexa

Citalopram hydrobromide Use and Manufacturing

Methods of Manufacturing

10g citalopram was heated and dissolved in 40mL isopropanol. After cooled down, pH of the solution was adjusted to 6-7 with bromic acid. The mixture was disposed with active carbon and filtrated, cooled down and placed aside to crystallize. Then the solution was filtrated and washed to give citalopram hydrobromic salt crystal. The obtained salt crystal was recrystallized to give 9.82g citalopram hydrobromic salt crystal with the yield of 88.2percent and the purity of 99.9percent (HPLC, area normalization method).

Uses

An inhibitor of serotonin (5-HT) uptake. Used as an antidepressant.

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:405.3
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:5
Exact Mass:404.08995
Monoisotopic Mass:404.08995
Topological Polar Surface Area:36.3
Heavy Atom Count:25
Complexity:466
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

1. It is a strong and selective 5-HT uptake inhibitor with antidepressant effect. 2. It has no inhibitory effect on cholinergic muscarinic receptors, histamine receptors and α-adrenergic receptors, reducing common side effects such as dry mouth, sedation, postural hypotension, etc. 3. It is equally effective for patients with endogenous and non-endogenous depression, and the antidepressant effect is usually established after 2-4 weeks. 4. It does not affect the cardiac conduction system and blood pressure, and is suitable for elderly patients. 5. It does not cause weight gain or enhance the effects of alcohol, and is suitable for long-term treatment.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • RAKS PHARMA PVT LTD

    United States United States
    Active
  • VIRUPAKSHA ORGANICS LTD

    United States United States
    Active
  • JUBILANT BIOSYS LTD

    United States United States
    Active

Recommended Suppliers of Citalopram hydrobromide

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.